HUE056172T2 - Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra - Google Patents

Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra

Info

Publication number
HUE056172T2
HUE056172T2 HUE16187342A HUE16187342A HUE056172T2 HU E056172 T2 HUE056172 T2 HU E056172T2 HU E16187342 A HUE16187342 A HU E16187342A HU E16187342 A HUE16187342 A HU E16187342A HU E056172 T2 HUE056172 T2 HU E056172T2
Authority
HU
Hungary
Prior art keywords
compositions
methods
selenoorganic compounds
selenoorganic
compounds
Prior art date
Application number
HUE16187342A
Other languages
English (en)
Inventor
Ronan Power
Zi-Jian Lan
Original Assignee
Alltech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alltech Inc filed Critical Alltech Inc
Publication of HUE056172T2 publication Critical patent/HUE056172T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
HUE16187342A 2014-03-14 2016-09-06 Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra HUE056172T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2014/029542 WO2015137983A1 (en) 2014-03-14 2014-03-14 Compositions of selenoorganic compounds and methods of use thereof
US14/855,128 US9642874B2 (en) 2014-03-14 2015-09-15 Compositions of selenoorganic compounds and methods of use thereof

Publications (1)

Publication Number Publication Date
HUE056172T2 true HUE056172T2 (hu) 2022-01-28

Family

ID=54072241

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE14885694A HUE051713T2 (hu) 2014-03-14 2014-03-14 Szelenoorganikus vegyületeket tartalmazó készítmények és ezek alkalmazása
HUE16187342A HUE056172T2 (hu) 2014-03-14 2016-09-06 Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE14885694A HUE051713T2 (hu) 2014-03-14 2014-03-14 Szelenoorganikus vegyületeket tartalmazó készítmények és ezek alkalmazása

Country Status (16)

Country Link
US (3) US10201559B2 (hu)
EP (1) EP3116511B1 (hu)
JP (2) JP6313479B2 (hu)
KR (3) KR102466389B1 (hu)
CN (3) CN113694074A (hu)
AU (4) AU2014386236B2 (hu)
BR (2) BR112016020233B1 (hu)
CA (1) CA2940283C (hu)
DK (2) DK3116511T3 (hu)
HU (2) HUE051713T2 (hu)
IL (1) IL247312A0 (hu)
MX (2) MX2016011897A (hu)
PE (1) PE20211069A1 (hu)
PT (1) PT3116511T (hu)
RU (2) RU2665135C2 (hu)
WO (2) WO2015137983A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016011897A (es) 2014-03-14 2017-04-27 Alltech Inc Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
CA2981138A1 (en) 2015-03-27 2016-10-06 The Research Foundation For The State University Of New York Methods and materials for reducing amyloid beta levels within a mammal
WO2017048252A1 (en) * 2015-09-15 2017-03-23 Alltech, Inc. Compositions of selenoorganic compounds and methods of use thereof
KR102054640B1 (ko) * 2015-09-24 2019-12-11 서울대학교산학협력단 아데노신 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
CA3017763A1 (en) * 2016-03-14 2017-09-21 Mitogenetics, Llc Materials and methods for treating hypoxic conditions
WO2018212980A1 (en) * 2017-05-19 2018-11-22 Alltech, Inc. Pharmaceutical agents, compositions, and methods relating thereto
JP7312184B2 (ja) 2017-10-23 2023-07-20 エピトラッカー インコーポレイテッド 脂肪酸アナログおよび代謝症候群に関連する症状の処置におけるそれらの使用
KR102083180B1 (ko) * 2017-11-09 2020-03-02 서울대학교산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법, 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
WO2019093699A1 (ko) * 2017-11-09 2019-05-16 서울대학교 산학협력단 셀레노사마필린 a와 그 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암 예방 및 치료용 조성물
CN108484690B (zh) * 2018-05-16 2021-04-30 新乡拓新药业股份有限公司 一种1,2,3-三-O-乙酰基-5-脱氧-β-D-核糖的制备方法
EP3908374A4 (en) * 2019-01-09 2022-12-28 Epitracker, Inc. COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
CN111543641A (zh) * 2020-04-27 2020-08-18 江苏惠利生物科技有限公司 一种提高l-硒-甲基硒代半胱氨酸稳定性以及生物利用率的方法
WO2022020658A1 (en) * 2020-07-23 2022-01-27 Purdue Research Foundation Notch signaling inhibitors for treating obesity and metabolic disorders
CN116421618B (zh) * 2023-06-15 2023-09-29 暨南大学 Se@NADH的制备方法及其在脊髓损伤治疗中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5463092A (en) 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
AU7361400A (en) 1999-09-08 2001-04-10 Metabasis Therapeutics, Inc. Prodrugs for liver specific drug delivery
PT1233770E (pt) 1999-12-03 2008-04-24 Univ California At San Diego Compostos de fosfonato
CA2397203A1 (en) 2000-03-31 2001-10-11 Sandra C. Tobias Phosphoramidate prodrugs
JP4942915B2 (ja) 2002-04-26 2012-05-30 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖプロテアーゼ阻害剤化合物のホスホネートアナログの細胞蓄積
NZ536327A (en) 2002-05-13 2007-08-31 Metabasis Therapeutics Inc PMEA and PMPA cyclic producing synthesis
WO2004037161A2 (en) 2002-05-13 2004-05-06 Metabasis Therapeutics, Inc. Cyclic prodrugs of pmea one of its analogues
PL214402B1 (pl) * 2003-08-11 2013-07-31 Tomasz Byrski Zastosowanie selenu albo jego zwiazku do otrzymywania srodka do obnizania odziedziczonego ryzyka zachorowania na raka piersi lub jajnika
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
EP1652519A1 (en) 2004-10-28 2006-05-03 Tamie Nasu Seleniferous composition for producing antioxidase in vivo
JP2006151965A (ja) 2004-10-28 2006-06-15 Mi Tec:Kk セレン含有組成物及びその製法
RU2371437C2 (ru) * 2004-12-31 2009-10-27 Сеул Нэшнл Юниверсити Индастри Фаундейшн Селенорганические соединения и их применение
US20060198906A1 (en) 2005-03-07 2006-09-07 Sami Labs Limited Compositions and Method to Increase Serum Levels of HDL cholesterol and Lower the Risk of Cardiovascular Disease
US20070077238A1 (en) 2005-10-04 2007-04-05 Teo Alex Y Production of organic and inorganic selenium compounds by lactic acid bacteria
CA2524551C (en) * 2005-10-14 2014-12-16 Alltech, Inc. Use of selenium yeasts in the treatment of alzheimer's disease
CN101073584B (zh) * 2005-10-14 2012-10-10 全面技术公司 改变细胞功能的方法和组合物
US20080004255A1 (en) 2005-10-14 2008-01-03 Alltech, Inc. Methods and compositions for altering cell function
US8865763B2 (en) 2005-10-14 2014-10-21 Alltech, Inc. Methods and compositions for altering cell function
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
US20080107755A1 (en) 2006-04-24 2008-05-08 Alltech, Inc. Methods and compositions for altering cell function
US8796241B2 (en) * 2007-08-29 2014-08-05 Adam Lubin Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase
US20110177140A1 (en) * 2007-08-31 2011-07-21 Rainer Voegeli 4-amidino benzylamines for cosmetic and/or dermatological use
EP2220208A4 (en) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res USE OF HAPTOGLOBIN GENOTYPING IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
CN101289495A (zh) * 2008-05-23 2008-10-22 浙江大学 含硒五肽化合物及其应用
PE20121709A1 (es) * 2009-10-22 2012-12-17 Propanc Pty Ltd Una composicion farmaceutica para tratar cancer que comprende tripsinogeno y/o quimotripsinogeno y un agente activo seleccionado a partir de un compuesto de selenio, un compuesto vainilloide y un agente reductor de glicolisis citoplasmica
JP5510302B2 (ja) * 2010-12-15 2014-06-04 トヨタ紡織株式会社 接続部材、その製造方法及び接続構造体
RU2605287C2 (ru) * 2011-04-01 2016-12-20 Иасомай АБ Новая комбинация, содержащая n-ацетил-l-цистеин, и ее применение
US20150057243A1 (en) 2012-04-02 2015-02-26 Northern University Compositions and Methods for the Inhibition of Methyltransferases
NL2010222C2 (en) * 2013-02-01 2014-08-04 Conradus Ghosal Gho Composition and method for generating a desired cell type and/or tissue type from hair follicular stem cells.
CN105377271A (zh) * 2013-03-15 2016-03-02 全技术公司 含硒组合物及其治疗和预防与线粒体功能障碍有关的疾病或病症的应用
MX2016011897A (es) 2014-03-14 2017-04-27 Alltech Inc Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
US20160000136A1 (en) * 2014-07-02 2016-01-07 Hamilton Beach Brands, Inc. Juice Extractor
US20160090397A1 (en) 2014-09-30 2016-03-31 Northeastern University Se-Adenosyl-L-Selenohomocysteine Selenoxide As A Modulator Of Methyltransferase And Other Activities

Also Published As

Publication number Publication date
CN113694074A (zh) 2021-11-26
US10201558B2 (en) 2019-02-12
BR112016020233A2 (hu) 2017-08-15
CA2940283C (en) 2021-03-30
US20160082033A1 (en) 2016-03-24
PE20211069A1 (es) 2021-06-09
AU2019246818B2 (en) 2021-02-25
WO2017048253A1 (en) 2017-03-23
AU2019246818A1 (en) 2019-10-31
US10201559B2 (en) 2019-02-12
KR20160125989A (ko) 2016-11-01
IL247312A0 (en) 2016-09-29
KR102448455B1 (ko) 2022-09-28
CN106456658A (zh) 2017-02-22
BR112016020233B1 (pt) 2022-07-19
PT3116511T (pt) 2020-11-19
US20160361338A1 (en) 2016-12-15
AU2014386236A1 (en) 2016-09-01
EP3116511A1 (en) 2017-01-18
RU2665135C2 (ru) 2018-08-28
EP3116511B1 (en) 2020-08-26
EP3116511A4 (en) 2017-10-18
CA2940283A1 (en) 2015-09-17
US20160045533A1 (en) 2016-02-18
DK3116511T3 (da) 2020-11-23
RU2731383C2 (ru) 2020-09-02
US9642874B2 (en) 2017-05-09
RU2016136530A (ru) 2018-03-16
AU2016222315A1 (en) 2017-03-30
JP2017512828A (ja) 2017-05-25
NZ723233A (en) 2020-10-30
MX2016011897A (es) 2017-04-27
KR102466389B1 (ko) 2022-11-11
JP6313479B2 (ja) 2018-04-18
JP2017078056A (ja) 2017-04-27
RU2016136530A3 (hu) 2019-11-25
KR20210104070A (ko) 2021-08-24
AU2016222315B2 (en) 2022-08-04
RU2016133469A (ru) 2018-04-17
HUE051713T2 (hu) 2021-03-29
AU2014386236B2 (en) 2019-07-11
KR20170032862A (ko) 2017-03-23
BR102016021058A2 (pt) 2017-05-30
CN106822168B (zh) 2020-11-27
AU2022204588A1 (en) 2022-07-21
WO2015137983A1 (en) 2015-09-17
CN106822168A (zh) 2017-06-13
DK3144001T3 (da) 2021-11-15
JP7009053B2 (ja) 2022-01-25
MX2016011898A (es) 2018-03-12

Similar Documents

Publication Publication Date Title
HRP20192145T1 (hr) Pripravci nosača-antitijela i metode pripreme i uporabe istih
HK1253049A1 (zh) 糖基相互作用化合物及其使用方法
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
IL251988A0 (en) Compounds acting on glycans and methods of using them
SI3102555T1 (sl) Sestavki spojin in njihove uporabe
ZA201701909B (en) Trichoderma compositions and methods of use
HUE050761T2 (hu) Vegyületek és alkalmazási eljárások
EP3190886A4 (en) Compositions and methods of use thereof
ZA201606450B (en) Compounds and their methods of use
HK1243404A1 (zh) 色酰胺組合物和使用方法
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
IL247645A0 (en) Preparations of seleno-organic compounds and methods of using them
GB2537518B (en) Settable compositions and methods of use
GB201403697D0 (en) Compounds and methods of use
ZA201606358B (en) Compositions of selenoorganic compounds and methods and methods of use thereof
GB201418410D0 (en) use of compositions of matter
AU2014905067A0 (en) Compositions and methods of use
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
AU2014902829A0 (en) Compositions and Methods of Use